Amag Pharmaceuticals, Inc. AMAG
We take great care to ensure that the data presented and summarized in this overview for AMAG PHARMACEUTICALS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in AMAG
Top Purchases
Top Sells
About AMAG
Insider Transactions at AMAG
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2020
|
Paul R. Fonteyne Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,676
-100.0%
|
-
|
|
Nov 16
2020
|
Anthony Casciano Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
76,349
-100.0%
|
-
|
|
Nov 16
2020
|
John A. Fallon Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
37,362
-100.0%
|
-
|
|
Nov 16
2020
|
Brian Piekos Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,538
-100.0%
|
-
|
|
Nov 16
2020
|
Kathrine O'Brien Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,949
-100.0%
|
-
|
|
Nov 16
2020
|
Gino Santini Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
41,473
-100.0%
|
-
|
|
Nov 16
2020
|
Joseph Vittiglio Chief Business Officer, GC |
SELL
Sale (or disposition) back to the issuer
|
Direct |
92,244
-100.0%
|
-
|
|
Nov 16
2020
|
James R Sulat Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,090
-100.0%
|
-
|
|
Nov 16
2020
|
Kelly Schick Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28,155
-100.0%
|
-
|
|
Nov 16
2020
|
Caligan Partners LP > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,499,428
-100.0%
|
-
|
|
Nov 16
2020
|
David Edward Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,499,428
-100.0%
|
-
|
|
Nov 16
2020
|
David Edward Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,676
-100.0%
|
-
|
|
Nov 16
2020
|
Anne M. Phillips Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,949
-100.0%
|
-
|
|
Nov 16
2020
|
Davey Scoon Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,898
-100.0%
|
-
|
|
Oct 01
2020
|
Camber Capital Management LP |
SELL
Open market or private sale
|
Indirect |
4,390,000
-100.0%
|
$57,070,000
$13.57 P/Share
|
|
Mar 16
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
24,000
+6.45%
|
$96,000
$4.87 P/Share
|
|
Feb 25
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
36,000
+5.36%
|
$288,000
$8.29 P/Share
|
|
Jan 27
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,000
+1.35%
|
$32,000
$4.71 P/Share
|
|
Jan 27
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,000
+0.19%
|
$72,000
$9.43 P/Share
|
|
Jan 24
2020
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+6.25%
|
$160,000
$4.86 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders